BANKOFJIUJIANG (06190) released its 2025 annual performance, with a net profit attributable to the mother of 827.5 million yuan, an increase of 11.2% year-on-year.
Jiujiang Bank (06190) announced its annual financial results as of December 31, 2025, with operating income of 10.477 billion yuan, a year-on-year increase of 0.9%; net profit attributable to the bank's shareholders was 827.5 million yuan, a year-on-year increase of 11.2%; basic earnings per share was 0.17 yuan, and it plans to distribute a cash dividend of 0.56 yuan (tax included) for every 10 shares.
BANKOFJIUJIANG(06190) released its annual performance for the year ending December 31, 2025. Operating income was RMB 10.477 billion, a year-on-year increase of 0.9%; net profit attributable to the bank's shareholders was RMB 827.5 million, a year-on-year increase of 11.2%; basic earnings per share were RMB 0.17, with a proposed cash dividend of RMB 0.56 (including tax) per 10 shares.
As of the end of the reporting period, the total assets of the group were RMB 523.435 billion, an increase of RMB 6.976 billion from the previous year, a growth of 1.4%, mainly due to an increase in customer loans and advances.
The group continued to optimize its business structure and strengthen capital management. As of the end of the reporting period, the group's capital adequacy ratio, Tier 1 capital adequacy ratio, and core Tier 1 capital adequacy ratio were 13.49%, 13.46%, and 8.87% respectively, meeting the requirements of the "Capital Management Measures for Commercial Banks".
Related Articles

Guangzhou Automobile Group (02238) plans to sell a 12% equity stake in Xinjiang Kunlun Blue Diamond Mining Development Co., Ltd. for 1.92 billion yuan.

TEDA BIOMEDICAL (08189) released its annual performance with a net loss of 90.82 million yuan attributable to shareholders, an increase of 226.67% year-on-year.

Sandmartin International (00482) releases annual financial performance, with a net loss attributable to shareholders of HK$115 million, a year-on-year increase of 274.84%.
Guangzhou Automobile Group (02238) plans to sell a 12% equity stake in Xinjiang Kunlun Blue Diamond Mining Development Co., Ltd. for 1.92 billion yuan.

TEDA BIOMEDICAL (08189) released its annual performance with a net loss of 90.82 million yuan attributable to shareholders, an increase of 226.67% year-on-year.

Sandmartin International (00482) releases annual financial performance, with a net loss attributable to shareholders of HK$115 million, a year-on-year increase of 274.84%.

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


